The DiMe Diversity, Equity, and Inclusion in Digitized Clinical Trials project will develop the best practices necessary to harness the promise of digital transformation of clinical trials to benefit all individuals, not just the over-represented few.
Diversity of data is a critical factor for advancing healthcare; this will only be achieved through equitable practices that ensure more inclusivity of underrepresented and underserved populations, in all steps of the clinical trials process, including recruitment, conduct, and data analysis.
We are proud to bring together life science companies; diversity, equity, and inclusion experts; and other leaders from the health-tech continuum together in this pre-competitive environment to advance the field for all.